Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aurobindo Pharma Ltd.

www.aurobindo.com

Latest From Aurobindo Pharma Ltd.

Indian Generics Firms Must Shift Gears For Third Wave, Says Lupin MD

Indian firms must transition from “plain-vanilla” generics to more complex products, including biosimilars, if they want to continue growing. However, returns from the sector’s so-called Third Wave will be some time coming, warns Lupin’s managing director Nilesh Gupta.

Generic Drugs Business Strategies

India Upholds Prevnar 13 Patent In Big Win For Pfizer

India has awarded Pfizer a patent for its blockbuster pneumonia vaccine Prevnar13, handing the pharmaceutical giant a big victory in a case which has been closely watched as a key test of the country’s patentability criteria.

Commercial Companies

Perrigo Draws On OTC Strength For Private Label Nexium 24HR Launch

Perrigo plans late September launch of a store brand OTC of Nexium 24HR after FDA’s ANDA approval and settlement of patent litigation with AstraZeneca. But it faces competition from Aurobindo's generic OTC esomeprazole 20 mg delayed-release capsules.

Consumer Prescription To Otc Switch

Time Is Of The Essence As Teva Considers European Assets Bids

Drug makers and private equity firms expected to submit their offers soon for Teva's oncology and pain businesses in Europe as the Israeli company bids to reduce debt by $5bn by the end of 2017.

M & A Cancer
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Aurobindo Pharma Ltd.
  • Senior Management
  • N Govindarajan, Mng. Dir.
  • Contact Info
  • Aurobindo Pharma Ltd.
    Phone: (91) 40 6672 5000
    WaterMark Bldg., Level 1
    Plot #11,Surv#9
    Hyderabad, 500 084
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register